SkyePharma net loss balloons
19th Apr 2006, 18:41 GMT
LONDON (Reuters) - Drug delivery firm SkyePharma unveiled a big annual loss and setbacks to several drug projects on Wednesday, but said it was confident of signing a long-delayed deal on a key asthma drug this year .
SkyePharma net loss balloons related news:
- SkyePharma net loss balloons — KeralaNext: Latest News
- Britain's SkyePharma Posts Loss (AP) — Yahoo! News: Earnings News
- SkyePharma boss blames rebels for poor results — Telegraph Business
- Endo ends Propofol IDD-D partnership — Latest news from Philadelphia Business Journal
- Skyepharma eyes asthma market — BBC News | Business | UK Edition
- Iona posts a first quarter loss — ElectricNews.net
- SkyePharma, Endo End Propofol Pact — FDA News News from StratCenter.com
- GM Reports $323 Million Net Loss — WSJ.com: What's News US
- Iona announces E486,000 net loss — BreakingNews.ie - Business
- Continental: operating profit, small net loss — bizjournals.com Travel:Airlines & Airports headlines
Latest news from Reuters: Shares:
- FTSE 100 set to edge up
- Playtech to buy Tribeca to join poker top table
- BT applies for long-distance licences in India
- DCC full-year outlook improves
- Wiseman Dairies profits jump
- BHP Billiton venture buys U.S. Gulf acreage
- Dawnay Day Treveria in share placing
- Majestic Wine profit rises
- Shipping broker ACM to float on AIM
- Newspaper round-up